JPMorgan Assumes BeiGene, Ltd. (BGNE) at Overweight, 'Pullback Creates an Entry Point'

February 6, 2024 7:10 AM EST Send to a Friend
JPMorgan analyst Jessica Fye assumes coverage on BeiGene, Ltd. (NASDAQ: BGNE) with a Overweight rating and a price target of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login